Director at Recursion (NASDAQ: RXRX) awarded 3,268 shares

Rhea-AI Filing Summary

Li Dean Y reported acquisition or exercise transactions in this Form 4 filing.

RECURSION PHARMACEUTICALS, INC. director Dean Y. Li received a grant of 3,268 shares of Class A Common Stock at $0.0000 per share. The shares were issued under the company’s Outside Director Compensation Policy, reflecting equity-based compensation rather than an open-market purchase.

Following this grant, Li directly owns 1,244,177 Class A shares. He also has indirect ownership through several entities, including the Dean Y. Li Revocable Trust, the Dean Y. Li GRAT, and the Dean Y. Li 2021 Family Trust, each with separately reported share balances.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Li Dean Y

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	3,268	$0.00	--
holding	Class A Common Stock	--	--	--
holding	Class A Common Stock	--	--	--
holding	Class A Common Stock	--	--	--

Holdings After Transaction: Class A Common Stock — 1,244,177 shares (Direct); Class A Common Stock — 1,422,048 shares (Indirect, By Dean Y. Li Revocable Trust)

Footnotes (1)

1. [object Object]

Key Figures

Stock grant: 3,268 shares Grant price: $0.0000 per share Direct holdings after grant: 1,244,177 shares +3 more

6 metrics

Stock grant 3,268 shares Class A Common Stock granted to director on 2026-04-01

Grant price $0.0000 per share Price for 3,268-share award under Outside Director Compensation Policy

Direct holdings after grant 1,244,177 shares Dean Y. Li direct Class A Common Stock position following transaction

Revocable Trust holdings 1,422,048 shares Class A Common Stock held indirectly by Dean Y. Li Revocable Trust

GRAT holdings 136,981 shares Class A Common Stock held indirectly by Dean Y. Li GRAT

2021 Family Trust holdings 421,000 shares Class A Common Stock held indirectly by Dean Y. Li 2021 Family Trust

Key Terms

Outside Director Compensation Policy, Grant, award, or other acquisition, Revocable Trust, GRAT, +1 more

5 terms

Outside Director Compensation Policy financial

"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Revocable Trust financial

"nature_of_ownership: By Dean Y. Li Revocable Trust"

A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.

GRAT financial

"nature_of_ownership: By Dean Y. Li GRAT"

Family Trust financial

"nature_of_ownership: By Dean Y. Li 2021 Family Trust"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Li Dean Y

(Last) (First) (Middle)

C/O RECURSION PHARMACEUTICALS

41 S. RIO GRANDE STREET

(Street)

SALT LAKE CITY UTAH 84101

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RECURSION PHARMACEUTICALS, INC. [ RXRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	04/01/2026		A(1)		3,268	A	$0	1,244,177	D
Class A Common Stock								1,422,048	I	By Dean Y. Li Revocable Trust
Class A Common Stock								136,981	I	By Dean Y. Li GRAT
Class A Common Stock								421,000	I	By Dean Y. Li 2021 Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.

Remarks:

	/s/ Jonathan Golightly, attorney-in-fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did RXRX director Dean Y. Li report in this Form 4?

Dean Y. Li reported receiving 3,268 shares of Recursion Class A Common Stock. The shares were issued at $0.0000 per share under the Outside Director Compensation Policy, increasing his directly held position while reflecting routine equity compensation for board service.

Is the RXRX Form 4 transaction a stock purchase or a grant?

The Form 4 shows a stock grant, not an open-market purchase. Code A indicates a grant or award, and footnotes state the 3,268 Class A shares were issued under Recursion’s Outside Director Compensation Policy at $0.0000 per share as equity compensation.

How many RXRX shares does Dean Y. Li hold directly after this grant?

After the grant, Dean Y. Li directly holds 1,244,177 shares of Recursion Class A Common Stock. This figure reflects his direct ownership position following the 3,268-share award reported in the Form 4 filed for the transaction date shown.

What indirect RXRX holdings are reported for Dean Y. Li?

Indirect holdings are reported through three entities: the Dean Y. Li Revocable Trust with 1,422,048 shares, the Dean Y. Li GRAT with 136,981 shares, and the Dean Y. Li 2021 Family Trust with 421,000 shares, each listed separately as indirect ownership entries.

What does the Outside Director Compensation Policy mean for RXRX insiders?

The Outside Director Compensation Policy provides equity awards to non-employee directors. In this filing, Recursion granted 3,268 Class A shares at $0.0000 per share to director Dean Y. Li, illustrating how the policy compensates board members using company stock instead of cash.

Were any RXRX shares sold in this Form 4 filing by Dean Y. Li?

No sales are reported in this Form 4. The filing records one acquisition coded A, representing a grant of 3,268 Class A shares, and several holding entries for indirect positions, with no entries indicating open-market or other dispositions of Recursion shares.